Advisors Asset Management Inc. Purchases 8,087 Shares of The Clorox Company (NYSE:CLX)

Advisors Asset Management Inc. boosted its position in The Clorox Company (NYSE:CLX) by 257.5% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 11,228 shares of the company’s stock after buying an additional 8,087 shares during the quarter. Advisors Asset Management Inc.’s holdings in Clorox were worth $1,719,000 at the end of the most recent reporting period.

Several other institutional investors have also recently bought and sold shares of CLX. Choreo LLC grew its position in shares of Clorox by 12.8% in the fourth quarter. Choreo LLC now owns 5,741 shares of the company’s stock valued at $819,000 after purchasing an additional 652 shares during the last quarter. abrdn plc boosted its stake in Clorox by 20.1% during the 4th quarter. abrdn plc now owns 198,250 shares of the company’s stock valued at $28,268,000 after purchasing an additional 33,135 shares during the period. Savoir Faire Capital Management L.P. grew its holdings in Clorox by 61.8% in the 4th quarter. Savoir Faire Capital Management L.P. now owns 65,192 shares of the company’s stock valued at $9,296,000 after buying an additional 24,897 shares during the last quarter. SG Americas Securities LLC increased its position in Clorox by 1,525.7% in the 1st quarter. SG Americas Securities LLC now owns 65,612 shares of the company’s stock worth $10,046,000 after buying an additional 61,576 shares during the period. Finally, Mizuho Markets Americas LLC lifted its holdings in shares of Clorox by 93.7% during the first quarter. Mizuho Markets Americas LLC now owns 72,053 shares of the company’s stock worth $11,032,000 after buying an additional 34,864 shares during the last quarter. Institutional investors own 78.53% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on CLX shares. UBS Group lowered their price objective on shares of Clorox from $164.00 to $159.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 1st. Barclays dropped their price objective on shares of Clorox from $132.00 to $122.00 and set an “underweight” rating on the stock in a report on Friday, July 19th. BNP Paribas started coverage on shares of Clorox in a research note on Monday, June 24th. They issued an “underperform” rating and a $130.00 target price for the company. Evercore ISI decreased their target price on Clorox from $145.00 to $142.00 and set an “underperform” rating on the stock in a research report on Wednesday, May 1st. Finally, TD Cowen began coverage on Clorox in a report on Tuesday, July 23rd. They issued a “sell” rating and a $122.00 price target for the company. Six analysts have rated the stock with a sell rating and fourteen have given a hold rating to the company’s stock. According to data from MarketBeat, Clorox currently has an average rating of “Hold” and a consensus price target of $142.13.

Clorox Stock Up 0.9 %

Shares of NYSE CLX opened at $134.61 on Friday. The Clorox Company has a 52-week low of $114.68 and a 52-week high of $169.14. The company has a debt-to-equity ratio of 9.73, a quick ratio of 0.53 and a current ratio of 0.90. The business has a fifty day moving average of $133.71 and a two-hundred day moving average of $142.66. The stock has a market cap of $16.72 billion, a PE ratio of 69.75, a PEG ratio of 1.98 and a beta of 0.39.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Tuesday, April 30th. The company reported $1.71 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.33 by $0.38. The firm had revenue of $1.81 billion during the quarter, compared to the consensus estimate of $1.87 billion. Clorox had a net margin of 3.33% and a return on equity of 302.49%. The firm’s quarterly revenue was down 5.3% on a year-over-year basis. During the same period last year, the firm posted $1.51 EPS. As a group, equities research analysts expect that The Clorox Company will post 5.91 earnings per share for the current fiscal year.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.